SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
SGNT was delisted on the 29th of August, 2016.
114 hedge funds and large institutions have $734M invested in SAGENT PHARMACEUTICALS INC COM STK (DE) in 2014 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 37 increasing their positions, 39 reducing their positions, and 13 closing their positions.
77% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 13
18% more capital invested
Capital invested by funds: $620M → $734M (+$114M)
10% more funds holding
Funds holding: 104 → 114 (+10)
5% less repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 39
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RIM
Ranger Investment Management
Dallas,
Texas
|
+$15.9M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$7.18M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.27M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$4.76M |
| 5 |
TCM
Timpani Capital Management
Milwaukee,
Wisconsin
|
+$3.63M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$17.1M |
| 2 |
BC
Broadfin Capital
New York
|
-$8.54M |
| 3 |
NIMC
NWQ Investment Management Company
Los Angeles,
California
|
-$7.71M |
| 4 |
Millennium Management
New York
|
-$5.39M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$5.12M |
SGNT Hedge Fund Activity: Q3 2014 in Review
114 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) for Q3 2014, worth a combined $734M — up 18% from $620M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new SGNT positions and 13 closed out — a net gain of 10 holders — while 37 added to existing stakes and 39 trimmed.
The largest buyer was Ranger Investment Management, opening a new position worth an estimated $15.9M. The largest seller was Franklin Resources, cutting an estimated $17.1M.
- 114 institutional investors held SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) as of Q3 2014, up from 104 in Q2 2014.
- Funds reported $734M of SAGENT PHARMACEUTICALS INC COM STK (DE) stock for Q3 2014, up 18% quarter-over-quarter.
- 23 funds opened new SAGENT PHARMACEUTICALS INC COM STK (DE) positions in Q3 2014 and 13 closed out, a net change of +10 holders.
- The largest SAGENT PHARMACEUTICALS INC COM STK (DE) buyer in Q3 2014 was Ranger Investment Management, an estimated $15.9M added.
- The largest SAGENT PHARMACEUTICALS INC COM STK (DE) seller in Q3 2014 was Franklin Resources, an estimated $17.1M sold.
Based on aggregated 13F filings for Q3 2014.